These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2623191)

  • 21. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
    Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
    Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man.
    Holm-Bentzen M; Christiansen J; Kirkegaard P; Olsen PS; Petersen B; Fahrenkrug J
    Scand J Gastroenterol; 1983 Jul; 18(5):659-61. PubMed ID: 6675186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Tatemoto K; Efendić S
    Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vasoactive intestinal polypeptide on renal function in man.
    Calam J; Dimaline R; Peart WS; Singh J; Unwin RJ
    J Physiol; 1983 Dec; 345():469-75. PubMed ID: 6363677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
    Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
    J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portal and systemic plasma VIP and secretin during intravenous infusion of Escherichia coli endotoxin in pigs.
    Lygren I; Revhaug A; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Nov; 19(8):1048-52. PubMed ID: 6398505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat.
    Humphrey CS; Murray P; Ebeid AM; Fischer JE
    Gastroenterology; 1979 Jul; 77(1):55-60. PubMed ID: 447028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
    Janosi T; Peták F; Fontao F; Morel DR; Beghetti M; Habre W
    Exp Physiol; 2008 Nov; 93(11):1210-9. PubMed ID: 18567602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
    Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
    Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G; Montuschi P; Currò D; Togna G; Preziosi P
    Br J Pharmacol; 1993 May; 109(1):243-50. PubMed ID: 8495242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental changes in binding sites and reactivity for CGRP and VIP in porcine pulmonary arteries.
    Hislop AA; Boels PJ; Deutsch J; Polak JM; Haworth SG
    Peptides; 1998; 19(4):703-14. PubMed ID: 9622026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vasoactive intestinal polypeptide (VIP) on pulmonary ventilation-perfusion relationships and central haemodynamics in healthy subjects.
    Söderman C; Eriksson LS; Juhlin-Dannfelt A; Lundberg JM; Broman L; Holmgren A
    Clin Physiol; 1993 Nov; 13(6):677-85. PubMed ID: 8119061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide (VIP) in preterm and term neonates.
    Lucas A; Bloom SR; Aynsley-Green A
    Acta Paediatr Scand; 1982 Jan; 71(1):71-4. PubMed ID: 7136620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli.
    Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ; Lauritsen KB
    Scand J Gastroenterol; 1977; 12(7):793-9. PubMed ID: 594650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?
    Keller J; Mueller-Wolf JC; Ahmadi-Simab K; Fibbe C; Rosien U; Layer P
    Dig Dis Sci; 2005 Feb; 50(2):276-82. PubMed ID: 15745085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
    Fahrenkrug J; Pedersen JH
    Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.
    Modlin IM; Bloom SR; Mitchell S
    Experientia; 1978 Apr; 34(4):535-6. PubMed ID: 639959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma vasoactive intestinal polypeptide in the newborn infant.
    Grisoni ER; Kalhan SC
    J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):185-8. PubMed ID: 2303969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide.
    Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; Bloom SR; Calam J
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E740-7. PubMed ID: 1415694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.